BARCELONA, Spain, Sept 10 (Bernama) -- Today, at the IASLC World Conference on Lung Cancer, the four founding partners of the Lung Ambition Alliance – the International Association for the Study of Lung Cancer (IASLC), Guardant Health, the Global Lung Cancer Coalition (GLCC) and AstraZeneca – announced the launch of several new initiatives to support their goal of doubling 5-year survival by 2025.
Giorgio Scagliotti, President of the IASLC said, “We have made tremendous progress in just two months since announcing the creation of the Lung Ambition Alliance. The Alliance’s new initiatives, like the Initiatives in Lung Cancer Care (ILC²), illustrate our shared goal to engage with the global community and encourage ambitious in-country solutions that can potentially transform patient care and improve survival rates in lung cancer.”
Mobil-branded lubricants and fluids to be used in Porsche Formula E race car
SPRING, Texas, Sept 10 (Bernama) -- ExxonMobil is expanding its global business and technical partnership with Porsche by teaming with the luxury German automaker on its Formula E series car for the 2019 / 2020 season. The new partnership represents ExxonMobil’s first entry into electric motorsports.
SINGAPORE, Sept 10 (Bernama) -- OraStream Private Limited is proud to announce that the company’s adaptive streaming technology has been featured in Neil Young’s new book “To Feel the Music: A Songwriter’s Mission to Save High-Quality-Audio.” Co-written with Phil Baker, the book tells the story of Neil Young’s efforts to improve the quality of audio that consumers hear.
The book describes the business and development story behind Pono and relates how Neil Young’s massive online archives, which the Guardian (UK) described as "a revolution in fandom," came about. Neil Young reveals how a unique adaptive streaming technology developed in Singapore made it possible to provide all of his music streaming in high resolution with the Neil Young Archives (www.neilyoungarchives.com).
SINGAPORE, Sept 10 (Bernama) -- AM Best has affirmed the Financial Strength Rating of B++ (Good) and the Long-Term Issuer Credit Rating of “bbb” of BIDV Insurance Corporation (BIC) (Vietnam). The outlook of these Credit Ratings (ratings) is stable.
The ratings reflect the company’s balance sheet strength, which AM Best categorizes as strong, as well as its adequate operating performance, neutral business profile and appropriate enterprise risk management (ERM). The ratings factor in a neutral impact from the company’s ultimate majority ownership by the Vietnam government.
KUALA LUMPUR, Sept 10 (Bernama) -- “Wow! Taiwan @ Malaysia I-Health Business Matching” was organized by the Commerce Development Research Institute (CDRI) and supported by the Bureau of Foreign Trade (BOFT) of Taiwan. Spire Research and Consulting (Malaysia) was appointed by CDRI in co-organizing the Business Matching “Wow! Taiwan” project concludes in triumph.
This event aims to introduce quality Taiwanese brands of various industrial fields to ASEAN consumers. “Wow! Taiwan” project has picked I-Health as the topic for this year.
NEW YORK, Sept 10 (Bernama) -- Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development of novel therapeutics to address global unmet medical needs, announces that it has initiated investigational new drug (IND)-enabling studies for ALS-4, a small drug molecule candidate indicated for the treatment of infections caused by Staphylococcus aureus (or “S. aureus”) including methicillin-resistant Staphylococcus aureus (MRSA, i.e., one of the commonly known “super-bugs”) based on a novel anti-virulence approach.
The ALS-4 candidate has been progressing well and the first series of GLP toxicology studies have been completed through an appointed North American based contract research organization (CRO). In particular, ALS-4 candidate did not show any mutagenicity in the in vitro
Ames tests. ALS-4 development is on track and the company targets to submit the related IND in the first half year of 2020 and a hybrid Phase 1 clinical study is currently planned in North America with both healthy volunteers and patients to obtain preliminary efficacy readout.
KUALA LUMPUR, Sept 6 (Bernama) -- The National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia (MOH) would like to urge the public to avoid buying and using this traditional product which has been detected to contain glibenclamide, a scheduled poison: